Literature DB >> 8083955

Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.

L M Carruth1, J M Hardwick, B A Morse, J E Clements.   

Abstract

Visna virus is a pathogenic lentivirus of sheep tat is distantly related to the primate lentiviruses, including human immunodeficiency virus type 1. The visna virus genome encodes a small regulatory protein, Tat, which is necessary for efficient viral replication and enhanced viral transcription. To investigate the mechanism of action of the visna Tat protein and to localize the protein domain(s) responsible for transcriptional activation, chimeric proteins containing visna virus Tat sequences fused to the DNA binding domain of the yeast transactivation factor GAL4 (residues 1 to 147) were made. The GAL4-Tat fusion proteins were transfected into cells and tested for the ability to activate the adenovirus E1b promoter via upstream GAL4 DNA binding sites. Full-length GAL4-Tat fusion proteins were weak transactivators in this system, giving only a two- to fourfold increase in transcription in several cell types, including HeLa and sheep choroid plexus cells. In contrast, fusion of the N-terminal region of the Tat protein to GAL4 revealed a potent activation domain. Amino acids 13 to 38 appeared to be the most critical for activation. No other region of the protein showed any activation in the GAL4 system. This N-terminal region of the visna virus Tat protein has a large number of acidic and hydrophobic residues, suggesting that Tat has an acidic activation domain common to many transcriptional transactivators. Mutations in hydrophobic and bulky aromatic residues dramatically reduced the activity of the chimeric protein. Competition experiments suggest that mechanism of the visna virus Tat activation domain may closely resemble that of the herpesvirus activator VP16 and human immunodeficiency virus Tat, a related lentivirus activator, since both significantly reduce the level of visna virus Tat activation. Finally, a domain between residues 39 and 53 was identified in the Tat protein that, in the GAL4 system, negatively regulates activation by Tat.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083955      PMCID: PMC237033     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro.

Authors:  F J Rauscher; P J Voulalas; B R Franza; T Curran
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

3.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

4.  The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice.

Authors:  J A Small; C Bieberich; Z Ghotbi; J Hess; G A Scangos; J E Clements
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites.

Authors:  D H Gabuzda; J L Hess; J A Small; J E Clements
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

6.  Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.

Authors:  J L Hess; J A Small; J E Clements
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Direct interaction of human TFIID with the HIV-1 transactivator tat.

Authors:  F Kashanchi; G Piras; M F Radonovich; J F Duvall; A Fattaey; C M Chiang; R G Roeder; J N Brady
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

9.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro.

Authors:  N Mermod; T J Williams; R Tjian
Journal:  Nature       Date:  1988-04-07       Impact factor: 49.962

10.  Common DNA binding site for Fos protein complexes and transcription factor AP-1.

Authors:  F J Rauscher; L C Sambucetti; T Curran; R J Distel; B M Spiegelman
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

View more
  10 in total

1.  Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4.

Authors:  W Xiao; L I Pizer; K W Wilcox
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.

Authors:  A K Ghosh; R Steele; R B Ray
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat.

Authors:  L M Carruth; B A Morse; J E Clements
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 4.  Molecular biology and pathogenesis of animal lentivirus infections.

Authors:  J E Clements; M C Zink
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

5.  Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.

Authors:  Udayan Chatterji; Aymeric de Parseval; John H Elder
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo.

Authors:  B A Morse; L M Carruth; J E Clements
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB.

Authors:  N M Rank; P F Lambert
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo.

Authors:  A Harmache; C Vitu; P Russo; M Bouyac; C Hieblot; P Peveri; R Vigne; M Suzan
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 10.  Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses.

Authors:  Deepanwita Bose; Jean Gagnon; Yahia Chebloune
Journal:  Vet Sci       Date:  2015-09-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.